Machine learning-assisted identification of optimal first-line treatment for newly diagnosed, transplant ineligible multiple myeloma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koo, Jamin | - |
dc.contributor.author | Park, Sung-Soo | - |
dc.contributor.author | Min, Chang-Ki | - |
dc.date.accessioned | 2023-03-10T05:40:58Z | - |
dc.date.available | 2023-03-10T05:40:58Z | - |
dc.date.created | 2023-03-10 | - |
dc.date.issued | 2022-08 | - |
dc.identifier.issn | 2152-2650 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hongik/handle/2020.sw.hongik/30896 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | CIG MEDIA GROUP, LP | - |
dc.title | Machine learning-assisted identification of optimal first-line treatment for newly diagnosed, transplant ineligible multiple myeloma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Koo, Jamin | - |
dc.identifier.wosid | 000895909200258 | - |
dc.identifier.bibliographicCitation | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.22, pp.S146 - S146 | - |
dc.relation.isPartOf | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - |
dc.citation.title | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - |
dc.citation.volume | 22 | - |
dc.citation.startPage | S146 | - |
dc.citation.endPage | S146 | - |
dc.type.rims | ART | - |
dc.type.docType | Meeting Abstract | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
94, Wausan-ro, Mapo-gu, Seoul, 04066, Korea02-320-1314
COPYRIGHT 2020 HONGIK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.